Literature DB >> 36268301

Antisynthetase syndrome and interstitial lung disease: A case report.

Krishna Dahal1, Anand Chaudhary1, Laba Rawal1, Umesh Ray1, Sandip Paudel1, Pitambar Khanal1, Pawan Gyawali1, Sanjit Kumar Sah1, Kishan Kumar Shrestha2, Shailendra Pandey1.   

Abstract

Introduction: Myositis, Raynaud's phenomenon, fever, interstitial lung disease, mechanic's hands, and arthropathy are symptoms of Antisynthetase Syndrome (ASS), which is defined by the development of antibodies against t-ribonucleic acid (RNA) synthetase, particularly anti-Jo-1. Case presentation: The case is about 29 years female with 1 month history of non-productive cough and dyspnea on exertion which was later diagnosed as ASS. Discussion: The diagnosis of an inflammatory myopathy is based on clinical findings such as subacute development of symmetrical muscle weakness and signs such as laboratory investigations revealing skeletal muscle inflammation. Creatinine phosphokinase (CPK) is mainly used to demonstrate skeletal muscle involvement.
Conclusion: Interstitial lung disease is a frequent occurrence and is associated with a bad prognosis during the course of antisynthetase syndrome.
© 2022 The Authors.

Entities:  

Keywords:  Antisynthetase syndrome; Case report; Interstitial lung disease; Non-specific interstitial pneumonia

Year:  2022        PMID: 36268301      PMCID: PMC9577423          DOI: 10.1016/j.amsu.2022.104571

Source DB:  PubMed          Journal:  Ann Med Surg (Lond)        ISSN: 2049-0801


  15 in total

1.  Efficacy of rituximab in refractory antisynthetase syndrome.

Authors:  V Limaye; P Hissaria; C-L Liew; B Koszyka
Journal:  Intern Med J       Date:  2012-03       Impact factor: 2.048

Review 2.  Myositis-related interstitial lung disease and antisynthetase syndrome.

Authors:  Joshua Solomon; Jeffrey J Swigris; Kevin K Brown
Journal:  J Bras Pneumol       Date:  2011 Jan-Feb       Impact factor: 2.624

Review 3.  Clinical spectrum of anti-Jo-1-associated disease.

Authors:  Sara Monti; Carlomaurizio Montecucco; Lorenzo Cavagna
Journal:  Curr Opin Rheumatol       Date:  2017-11       Impact factor: 5.006

Review 4.  Antisynthetase syndrome pathogenesis: knowledge and uncertainties.

Authors:  Laure Gallay; Catherine Gayed; Baptiste Hervier
Journal:  Curr Opin Rheumatol       Date:  2018-11       Impact factor: 5.006

Review 5.  Clinical manifestations and treatment of antisynthetase syndrome.

Authors:  Joanna L Marco; Bridget F Collins
Journal:  Best Pract Res Clin Rheumatol       Date:  2020-04-11       Impact factor: 4.098

Review 6.  Interstitial lung disease associated with the idiopathic inflammatory myopathies: what progress has been made in the past 35 years?

Authors:  Geoffrey R Connors; Lisa Christopher-Stine; Chester V Oddis; Sonye K Danoff
Journal:  Chest       Date:  2010-12       Impact factor: 9.410

7.  Jo1-antisynthetase syndrome and severe interstitial lung disease with organising pneumonia on histopathology with favourable outcome on early combined treatment with corticosteroids, mycophenolate mofetil and rituximab.

Authors:  Christine A Rüegg; Britta Maurer; Irène Laube; Dieter Scholtze
Journal:  BMJ Case Rep       Date:  2019-09-12

8.  Antisynthetase syndrome presenting as rheumatoid-like polyarthritis.

Authors:  Gregory E Mumm; Kevin M McKown; Carolyn L Bell
Journal:  J Clin Rheumatol       Date:  2010-10       Impact factor: 3.517

9.  Antisynthetase Syndrome: A Rare Cause for ILD.

Authors:  Hj Gayathri Devi; Md Majeed Pasha; Mantha Sathya Padmaja; Sujith Halappa
Journal:  J Clin Diagn Res       Date:  2016-03-01

10.  Anti-synthetase syndrome presenting with interstitial lung disease.

Authors:  Panagiotis Athanassiou; Markos Kostopoulos; Aikaterini Tzanavari; Anestis Spyridis; Ifigenia Kostoglou-Athanassiou
Journal:  Mediterr J Rheumatol       Date:  2017-12-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.